Healthcare · NIFTY 500
Rubicon Research Limited
NSERUBICON
BSE544578 ISININE506V01022 SeriesEQ Listed on NSE · BSE
₹1,717.30 -6.00 (-0.35%) Updated 12 Nov, 8:49 pm IST
Price, daily close+154.24% in a year
Today
- Open
- ₹1,723.30
- Prev close
- ₹1,723.30
- Day high
- ₹1,746.90
- Day low
- ₹1,704.10
- Volume
- 69.3 K
- Value traded
- ₹11.93 Cr
- Upper circuit
- ₹2,067.90
- Lower circuit
- ₹1,378.70
- 52W high
- ₹1,899.00
- 52W low
- ₹609.25
- 1 month
- +8.07%
- 6 months
- +74.40%
52W low52W high
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Market cap₹28,426 Cr
P/E (TTM)88.07
P/B20.07
Book value / share₹85.56
EPS (TTM)₹19.50
ROE22.9%
Dividend yield0.09%
Dividend (12m)₹1.50 / share
Net margin (TTM)15.5%
Operating margin25.0%
Debt / equity0.28
Current ratio1.83
EV / EBITDA57.23
Sales growth (YoY qtr)+39.89%
Profit growth (YoY qtr)+68.01%
Sales CAGR 3Y—
Profit CAGR 3Y—
Shares16.55 Cr
Quarterly results
Results for each quarter
Last 5 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Revenue · QoQ (vs last quarter)
—+15%+8.1%+4.0%+7.9%
Revenue · YoY (vs a year ago)
————+40%
Net profit · QoQ (vs last quarter)
—+35%+5.5%+10%+6.7%
Net profit · YoY (vs a year ago)
————+68%
RevenueNet profitLine = trend
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
EPS (₹) · YoY (vs a year ago)
————+56%
EPS (₹)Line = trend
| ₹ Cr | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|
| Revenue | 412 | 476 | 514 | 534 | 576 |
| Other income | 0.7 | 3.8 | 2.6 | 5.7 | 2.3 |
| Total income | 413 | 479 | 517 | 540 | 579 |
| Raw material | 142 | 184 | 155 | 154 | 175 |
| Purchases | 21.2 | 21.8 | 45.0 | 22.1 | 13.0 |
| Employee cost | 63.4 | 66.4 | 68.4 | 85.7 | 90.5 |
| Other expenses | 128 | 144 | 158 | 151 | 161 |
| Total expenses | 341 | 389 | 418 | 430 | 462 |
| Operating profit | 94.3 | 108 | 119 | 129 | 144 |
| OPM % | 22.9% | 22.7% | 23.1% | 24.2% | 25.0% |
| Finance cost | 11.4 | 9.8 | 10.4 | 9.3 | 11.4 |
| Depreciation | 11.9 | 11.6 | 12.3 | 15.1 | 18.0 |
| Profit before tax | 71.7 | 90.6 | 98.7 | 110 | 117 |
| Tax | 17.9 | 17.8 | 21.9 | 25.6 | 26.5 |
| Net profit | 53.9 | 72.8 | 76.8 | 84.8 | 90.4 |
| Profit to shareholders | 53.9 | 72.8 | 76.8 | 84.8 | 90.5 |
| EPS (₹) | 3.47 | 4.41 | 4.60 | 5.08 | 5.41 |
Profit & loss
Results for each year
1 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
FY26
RevenueOperating profitNet profitLine = trend
| ₹ Cr | FY26 |
|---|---|
| Revenue | 1,754 |
| Other income | 7.7 |
| Total expenses | 1,441 |
| Employee cost | 256 |
| Operating profit | 400 |
| OPM % | 22.8% |
| Finance cost | 42.2 |
| Depreciation | 45.3 |
| Profit before tax | 321 |
| Tax | 73.8 |
| Tax rate % | 23.0% |
| Net profit | 247 |
| Profit to shareholders | 247 |
| Net margin % | 14.1% |
| EPS (₹) | 15.31 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Mar 26
Sep 26
Shareholders' equityBorrowingsCashLine = trend
| ₹ Cr | Mar 26 | Sep 26 |
|---|---|---|
| Shareholders' equity | 1,289 | 1,416 |
| Long-term borrowings | 143 | 188 |
| Short-term borrowings | 116 | 210 |
| Total borrowings | 259 | 398 |
| Current liabilities | 836 | 953 |
| Fixed assets (PPE) | 467 | 526 |
| Inventories | 729 | 790 |
| Trade receivables | 509 | 578 |
| Cash & equivalents | 186 | 209 |
| Current assets | 1,682 | 1,747 |
| Total assets | 2,327 | 2,761 |
| Debt / equity | 0.20 | 0.28 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
FY26
OperationsInvestingFinancingLine = trend
| ₹ Cr | FY26 |
|---|---|
| Cash from operations | 205 |
| Cash from investing | -410 |
| Cash from financing | 283 |
| Spent on fixed assets | -229 |
| Free cash flow | -24.1 |
| Net cash flow | 78.4 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Promoter & groupPublic
Latest (30 Sep 2026)
51.3%promoter
- Promoter & group
- 51.25%
- Public (FIIs, mutual funds, retail…)
- 48.75%
- Promoter change, last quarter
- -8.51 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 1.50 Per Share
Board meetings
- Rubicon Research Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Fin…
- the financial results for the period ended September 30, 2026
- Rubicon Research Limited has informed the Exchange about Board Meeting to be held on 14-Aug-2026 to inter-alia consider and approve the Unaudited Fin…
- the financial results for the period ended Jun 30, 2026
- the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
Filings with NSE
- General Updates
- General Updates
- General Updates
- Monitoring Agency Report
- Monitoring Agency Report
- Investor Presentation
- Outcome of Board Meeting
Latest news
3 Indian Growth Stocks With Earnings Growth Up To 46%Simply Wall St · 12 Nov, 10:53 amRUBICON RESEARCH Share Price weakens on latest moveUnivest · 22 Oct, 12:30 pmRubicon Research Gets One USFDA Observation; Shares DownEquitypandit · 12 Oct, 12:30 pmRubicon Research zooms 166% in CY2026; hits new high post Q1 resultsBusiness Standard · 17 Aug, 12:30 pmBlock Deals: Promoter General Atlantic sells over 8% Rubicon Research stake; Ribbit Capital offloads Rs...Moneycontrol.com · 26 Aug, 12:30 pmRubicon Research Share Price Falls 3.67%: Valuation CheckUnivest · 21 Oct, 12:30 pmRubicon Research zooms 128% so far in 2026; what's driving pharma stock?Business Standard · 23 Jul, 12:30 pm3 Indian Growth Stocks With Revenue Growth Over 24%Simply Wall St · 10 Nov, 7:03 amAbout
About Rubicon Research Limited
Rubicon Research Limited is listed on the NSE under the symbol RUBICON and belongs to the Healthcare sector.
Company details
- Company name
- Rubicon Research Limited
- NSE symbol
- RUBICON
- BSE scrip code
- 544578
- ISIN
- INE506V01022
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 16 Oct 2025
- Face value
- ₹1 per share
- Market lot
- 1 share
- Shares issued
- 16.55 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Biotechnology
- Managing director / CEO
- Parag Sancheti
- Chair
- Venkat Changavalli
- Headquarters
- Thane, IN
- Founded
- 1999
- Employees
- 1,303
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- rubicon.co.in
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories
₹11,485.00
+1.04%
-
ALKEMAlkem Laboratories
₹5,302.00
-2.68%
-
GRANULESGranules India
₹840.50
+5.16%
-
SUNPHARMASun Pharmaceutical Industries
₹1,885.00
-0.91%
-
LAURUSLABSLaurus Labs
₹2,400.00
-1.19%
-
AUROPHARMAAurobindo Pharma
₹1,807.20
-1.11%
-
ACUTAASAcutaas Chemicals
₹3,996.10
+2.02%
-
APOLLOHOSPApollo Hospitals Enterprise
₹8,515.00
-1.03%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.